Duyuru • Mar 26
Allianz Global Investors Deutschland GmbH agreed to acquire an unknown majority stake in Amprion GmbH from Talanx AG (XTRA:TLX) Allianz Global Investors Deutschland GmbH agreed to acquire an unknown majority stake in Amprion GmbH from Talanx AG (XTRA:TLX) on March 26, 2026.
Moritz Petersen, Frank Scholderer, Annette Röhder, Gregor Evenkamp, Dimitri Slobodenjuk, Anne Filzmoser of Clifford Chance LLP acted as legal advisor for Talanx AG.
The transaction is expected to be completed in the second quarter of 2026, subject to the usual closing conditions. Duyuru • Nov 14
Talanx Ag Provides Consolidated Earnings Guidance for the Financial Year 2026 and 2027 Talanx Ag provided Consolidated Earnings Guidance for the Financial Year 2026 and 2027. For the year, the company expects consolidated net income of approximately EUR 2.7 billion for the financial year 2026.
For the year, the company expects increase the consolidated net income generated in the financial year 2024 by 30% to around EUR 2.57 billion by 2027. Reported Earnings • Aug 18
Second quarter 2025 earnings released: EPS: €2.98 (vs €1.99 in 2Q 2024) Second quarter 2025 results: EPS: €2.98 (up from €1.99 in 2Q 2024). Revenue: €12.0b (up 36% from 2Q 2024). Net income: €769.0m (up 50% from 2Q 2024). Profit margin: 6.4% (up from 5.8% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Aug 18
Talanx AG (XTRA:TLX) announces an Equity Buyback for 400,000 shares, representing 0.15% for €48 million. Talanx AG (XTRA:TLX) announces a share repurchase program. Under the program, the company will repurchase up to 400,000 shares, representing approximately 0.15% of its issued share capital for a total of €48 million. The purpose of the program is to meet the obligations in connection with the share option program for the employees. The repurchased shares will be offered to the employees participating under the employee share program 2025. The repurchase program will expire on December 31, 2025. Duyuru • Mar 28
Talanx AG, Annual General Meeting, May 08, 2025 Talanx AG, Annual General Meeting, May 08, 2025, at 10:30 W. Europe Standard Time. Duyuru • Feb 07
Talanx AG to Report First Half, 2025 Results on Aug 14, 2025 Talanx AG announced that they will report first half, 2025 results on Aug 14, 2025 Reported Earnings • Nov 15
Third quarter 2024 earnings released: EPS: €1.95 (vs €1.79 in 3Q 2023) Third quarter 2024 results: EPS: €1.95 (up from €1.79 in 3Q 2023). Revenue: €9.26b (down 4.2% from 3Q 2023). Net income: €502.0m (up 11% from 3Q 2023). Profit margin: 5.4% (up from 4.7% in 3Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 24% per year. Reported Earnings • Aug 15
Second quarter 2024 earnings released: EPS: €2.00 (vs €1.59 in 2Q 2023) Second quarter 2024 results: EPS: €2.00 (up from €1.59 in 2Q 2023). Revenue: €15.5b (up 44% from 2Q 2023). Net income: €518.0m (up 28% from 2Q 2023). Profit margin: 3.3% (down from 3.8% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.3% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 23% per year. Reported Earnings • May 17
First quarter 2024 earnings released: EPS: €2.22 (vs €1.67 in 1Q 2023) First quarter 2024 results: EPS: €2.22 (up from €1.67 in 1Q 2023). Revenue: €12.0b (down 6.4% from 1Q 2023). Net income: €572.0m (up 35% from 1Q 2023). Profit margin: 4.7% (up from 3.3% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Insurance industry in Europe. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 27% per year. Reported Earnings • Mar 24
Full year 2023 earnings released Full year 2023 results: Revenue: €53.2b (up 7.2% from FY 2022). Net income: €1.58b (up 35% from FY 2022). Profit margin: 3.0% (up from 2.4% in FY 2022). Revenue is forecast to grow 8.0% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Insurance industry in Germany. Declared Dividend • Mar 24
Dividend increased to €2.35 Dividend of €2.35 is 18% higher than last year. Ex-date: 8th May 2024 Payment date: 10th May 2024 Dividend yield will be 3.3%, which is lower than the industry average of 3.8%. Sustainability & Growth Dividend is well covered by both earnings (33% earnings payout ratio) and cash flows (8% cash payout ratio). The dividend has increased by an average of 6.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 5.4% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Duyuru • Jan 09
Talanx AG to Report Fiscal Year 2023 Results on Feb 08, 2024 Talanx AG announced that they will report fiscal year 2023 results on Feb 08, 2024 Reported Earnings • Nov 15
Third quarter 2023 earnings released: EPS: €15,047 (vs €0.89 in 3Q 2022) Third quarter 2023 results: EPS: €15,047 (up from €0.89 in 3Q 2022). Revenue: €35t (up €35t from 3Q 2022). Net income: €3.81t (up €3.81t from 3Q 2022). Profit margin: 11% (up from 1.8% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is expected to decline by 70% p.a. on average during the next 3 years, while revenues in the Insurance industry in Germany are expected to grow by 4.8%. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has increased by 25% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Oct 24
Talanx Ag Provides Earnings Guidance for the Financial Year 2023 Talanx AG provided earnings guidance for the financial year 2023. For the year, the company expects consolidated net income for the full financial year 2023 that will significantly exceed EUR 1.5 billion. Duyuru • Oct 21
Talanx AG to Report Fiscal Year 2023 Results on Mar 21, 2024 Talanx AG announced that they will report fiscal year 2023 results on Mar 21, 2024 New Risk • Oct 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company. Price Target Changed • Sep 28
Price target increased by 8.4% to €58.00 Up from €53.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of €58.10. Stock is up 65% over the past year. The company is forecast to post earnings per share of €5.93 for next year compared to €4.63 last year. Duyuru • Sep 21
Talanx AG has completed a Follow-on Equity Offering in the amount of €301.35 million. Talanx AG has completed a Follow-on Equity Offering in the amount of €301.35 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 4,900,000
Price\Range: €61.5
Transaction Features: Subsequent Direct Listing Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: €1.59 (vs €1.70 in 2Q 2022) Second quarter 2023 results: EPS: €1.59 (down from €1.70 in 2Q 2022). Revenue: €10.7b (up 37% from 2Q 2022). Net income: €404.0m (down 6.0% from 2Q 2022). Profit margin: 3.8% (down from 5.5% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 26% per year. Duyuru • Jul 24
Talanx AG to Report Q3, 2023 Results on Nov 13, 2023 Talanx AG announced that they will report Q3, 2023 results at 1:30 PM, Central European Standard Time on Nov 13, 2023 Price Target Changed • Jul 04
Price target increased by 8.2% to €52.70 Up from €48.71, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of €52.55. Stock is up 53% over the past year. The company is forecast to post earnings per share of €5.58 for next year compared to €4.63 last year. Duyuru • May 17
Talanx AG to Report Q1, 2023 Results on May 15, 2023 Talanx AG announced that they will report Q1, 2023 results at 7:30 AM, Central European Standard Time on May 15, 2023 Upcoming Dividend • Apr 30
Upcoming dividend of €1.50 per share Eligible shareholders must have bought the stock before 07 May 2021. Payment date: 11 May 2021. Trailing yield: 4.3%. Within top quartile of German dividend payers (3.1%). In line with average of industry peers (4.2%). Reported Earnings • Mar 17
Full year 2020 earnings released: EPS €2.66 (vs €3.65 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: €39.5b (up 2.9% from FY 2019). Net income: €673.0m (down 27% from FY 2019). Profit margin: 1.7% (down from 2.4% in FY 2019). The decrease in margin was driven by higher expenses. Combined ratio: 100.9% (up from 98.3% in FY 2019). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Is New 90 Day High Low • Feb 16
New 90-day high: €33.90 The company is up 6.0% from its price of €31.94 on 18 November 2020. The German market is up 11% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Insurance industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €73.96 per share. Is New 90 Day High Low • Jan 06
New 90-day high: €33.52 The company is up 15% from its price of €29.06 on 08 October 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €83.66 per share. Reported Earnings • Nov 14
Third quarter 2020 earnings released: EPS €2.06 The company reported a soft third quarter result with weaker earnings and profit margins, although revenues were improved. Third quarter 2020 results: Revenue: €10.2b (up 4.6% from 3Q 2019). Net income: €194.0m (down 27% from 3Q 2019). Profit margin: 1.9% (down from 2.7% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 4% per year. Analyst Estimate Surprise Post Earnings • Nov 14
Revenue beats expectations Revenue exceeded analyst estimates by 0.6%. Earnings per share (EPS) were mostly in line with analyst estimates. Over the next year, revenue is expected to shrink by 9.9% compared to a 16% growth forecast for the Insurance industry in Germany. Valuation Update With 7 Day Price Move • Nov 11
Market bids up stock over the past week After last week's 19% share price gain to €31.78, the stock is trading at a trailing P/E ratio of 10.4x, up from the previous P/E ratio of 8.8x. This compares to an average P/E of 11x in the Insurance industry in Germany. Total returns to shareholders over the past three years are 5.6%. Is New 90 Day High Low • Oct 26
New 90-day low: €26.38 The company is down 19% from its price of €32.60 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is down 11% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €62.71 per share. Is New 90 Day High Low • Sep 19
New 90-day low: €29.54 The company is down 11% from its price of €33.08 on 19 June 2020. The German market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Insurance industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €66.04 per share.